|Dermira Inc -- USA Stock|| |
USD 28.06 0.21 0.75%
Co-Founder and VP of Corporate Devel. and Strategy
Mr. Christopher M. Griffith is Senior Vice President Corporationrationrate Development and Strategy, Founder of the Company. He founded our company in August 2010 and has served as our Senior Vice President of Corporationrationrate Development and Strategy since January 2017, after previously serving as our Vice President of Corporationrationrate Development and Strategy since August 2011 and Head of Corporationrationrate Development and Strategy since September 2010. From July 2005 to September 2010, Mr. Griffith worked in corporate development at Gilead Sciences, Inc., most recently as Associate Director of Corporationrationrate Development. From May 2004 to August 2004, Mr. Griffith worked in the biooncology strategy group at Genentech, Inc., a biotechnology company. From 2001 to 2003, Mr. Griffith worked at Bay City Capital
Age: 39 Founder Since 2017 MBA
650 421-7200 www.dermira.com
Griffith received B.S. and M.S. degrees in biological sciences from Stanford University and an M.B.A. degree from Harvard Business School.
The company has return on total asset (ROA)
of (12.62) %
which means that it has lost $12.62 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (31.39) %
meaning that it created substantial loss on money invested by shareholders.
The company currently holds 278.47 M in liabilities with Debt to Equity (D/E) ratio of 74.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Dermira Inc has Current Ratio of 23.94 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Dermira, Inc., a biopharmaceutical company, engages in identifying, developing, and commercializing therapies to enhance the lives of patients with dermatologic diseases primarily in the United States. Dermira Inc (DERM) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 62 people. Dermira is listed under Pharmaceutical Products category by Fama And French industry classification.